Cargando…
Hypoxia Mediates Differential Response to Anti-EGFR Therapy in HNSCC Cells
Despite advances in the head and neck squamous cell carcinoma (HNSCC) treatment modalities, drug resistance and cancer recurrence are often reported. Hypoxia signaling through hypoxia-inducible factor 1 (HIF-1) promotes angiogenesis and metastasis by inducing epithelial-mesenchymal-transition (EMT)....
Autores principales: | Wiechec, Emilia, Hansson, Katharina Tiefenböck, Alexandersson, Lisa, Jönsson, Jan-Ingvar, Roberg, Karin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5454856/ https://www.ncbi.nlm.nih.gov/pubmed/28468237 http://dx.doi.org/10.3390/ijms18050943 |
Ejemplares similares
-
Hypoxia induces radioresistance, epithelial-mesenchymal transition, cancer stem cell-like phenotype and changes in genes possessing multiple biological functions in head and neck squamous cell carcinoma
por: Wiechec, Emilia, et al.
Publicado: (2022) -
Prognostic value of hypoxia-responsive gene expression profile in patients diagnosed with head and neck squamous cell carcinoma
por: Matic, Natasa, et al.
Publicado: (2023) -
CAFs affect the proliferation and treatment response of head and neck cancer spheroids during co-culturing in a unique in vitro model
por: Magan, Mustafa, et al.
Publicado: (2020) -
In vitro measurement of glucose uptake after radiation and cetuximab treatment in head and neck cancer cell lines using 18F-FDG, gamma spectrometry and PET/CT
por: Matic, Natasa, et al.
Publicado: (2019) -
WRAP53β, survivin and p16(INK4a) expression as potential predictors of radiotherapy/chemoradiotherapy response in T2N0-T3N0 glottic laryngeal cancer
por: Tiefenböck-Hansson, Katharina, et al.
Publicado: (2017)